Skip to main content

Cell and Gene Therapy Catapult (CGT Catapult) Resources

The Cell and Gene Therapy Catapult (CGT Catapult) is an independent not-for-profit innovation and technology organisation committed to the advancement of cell and gene therapies. 

Key information and resources provided on the site include:


New guidance on the development and marketing of ATMPs in the UK and EU in the post-BREXIT landscape

CGT Catapult's guide on legislative changes regarding the development and marketing of ATMPs in the UK and EU post-BREXIT

CGT Catapult Viral Vectors Supply Challenge

Viral vectors: what are the solutions to current scale up challenges?

CGT Catapult's presentation on current state of viral vector manufacturing, barriers, and solutions. 

CGT Catapult: Taking ATMPs to Market

Taking ATMPs to Market

CGT Catapult's presentation on the regulatory framework for ATMPs in the EU, therapy classification, development support and market access pathways

cgt catapult

Creating EU market access roadmaps for cell and gene therapies

CGT Catapult's information on market access processes for cell and gene therapies in EU

cgt catapult

Preparing for commercial GMP manufacture

aspects to consider when preparing for commercial GMP manufacture
cgt catapult

Past and present experience of ATMP in the UK to inform future best practice

Report by CGT Catapult summarising challenges in the UK ATMP ecosystem.
cgt catapult

Cell Confluency Tool

CGT Catapult's tool to help determine the confluency of cell cultures in an unbiased way

Additional information and resources developed by CGT Catapult:

Did you find the content on this page useful? If not, you can leave us a message so we can improve Send us your thoughts